80 results
Page 3 of 4
6-K
EX-99
ht2v2gsy
26 Nov 13
Current report (foreign)
12:00am
6-K
EX-99
g5khoz3
19 Nov 13
BioLineRx Reports Publication in Peer Review Journal
12:00am
6-K
EX-99
onnof
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
dq5ri87t7l
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
6-K
EX-99
vvgke 8dhws
17 Sep 13
BioLineRx Announces Receipt of a Notice of Allowance
12:00am
424B3
n9qp4nnc
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
wpuoc4q
10 Jun 13
Current report (foreign)
12:00am
6-K
EX-99
xhhmjzn9
29 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
o9j6hfkv1 yvuh
17 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
ty1fsyd2cocp2sd0ejdw
13 Mar 13
BioLineRx Receives Approval from French Regulatory
12:00am
6-K
EX-99
r59o7jk1 619o
28 Feb 13
Current report (foreign)
12:00am
424B5
9txtm90dugq
6 Feb 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
az2x55
16 Oct 12
BioLineRx Announces Successful Completion of Pre-Clinical
12:00am
424B3
4yra1r2baobglnlgh03
15 Oct 12
Prospectus supplement
12:00am
F-1
8r2ecgv9
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
127v37d rqkue0
10 Sep 12
BioLineRx Announces Pre-clinical Results Demonstrating
12:00am
6-K
EX-99
itxw03i 73
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
6-K
EX-99
5nanufa hte
9 Jul 12
BioLineRx Receives Notice of Intention to Grant
12:00am
6-K
EX-99
q0hla3ja41bc ktab
5 Jun 12
BioLineRx Announces Receipt of Two Notices of
12:00am